Your session is about to expire
← Back to Search
Soft Contact Lens
senofilcon A/balafilcon A for Refractive Errors
N/A
Waitlist Available
Research Sponsored by Johnson & Johnson Vision Care, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after 4 weeks of lens wear
Awards & highlights
No Placebo-Only Group
Summary
This study seeks to evaluate the clinical and subjective performance of two established soft contact lenses.
Eligible Conditions
- Refractive Errors
- Near-sightedness
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ after 4 weeks of lens wear
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after 4 weeks of lens wear
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Patient-reported Comfort at at the Manufacturer's Recommended Lens Replacement Timeframe of 2-weeks (Senofilcon A) or 4-weeks (Balafilcon A).
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: senofilcon A/balafilcon AActive Control2 Interventions
senofilcon A silicone hydrogel contact lens worn during first 4-week period, balafilcon A silicone hydrogel contact lens worn during the second 4-week period. Senofilcon A lenses worn daily on a 2-week replacement schedule; balafilcon A lenses worn daily on a 4-week replacement schedule. Lens replacement conducted in-office in a masked process.
Group II: balafilcon A/senofilcon AActive Control2 Interventions
balafilcon A silicone hydrogel contact lens worn worn during first 4-week period, senofilcon A silicone hydrogel contact lens worn during the second 4-week period. Senofilcon A lenses worn daily on a 2-week replacement schedule; balafilcon A lenses worn daily on a 4-week replacement schedule. Lens replacement conducted in-office in a masked process.
Find a Location
Who is running the clinical trial?
Johnson & Johnson Vision Care, Inc.Lead Sponsor
219 Previous Clinical Trials
25,751 Total Patients Enrolled
22 Trials studying Refractive Errors
1,996 Patients Enrolled for Refractive Errors
Share this study with friends
Copy Link
Messenger